At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 26 enrolled
Drug / intervention
IW-1973 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2 Study to Compare the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 2 Dose Regimens of IW-1973 in Patients With Stable Type 2 Diabetes and Hypertension
In Brief
A Phase 2 clinical trial evaluating IW-1973 and Placebo for Diabetes Mellitus, Type 2 and Hypertension. Completed, enrolled 26 participants across 1 site.
Detailed Summary
To compare the safety, tolerability, pharmacokinetic (PK) profile, and pharmacodynamic (PD) effects of 2 treatment regimens of IW-1973 tablet (40 mg per day) administered orally for 2 weeks to patients with stable type 2 diabetes mellitus and hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Hypertension
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartFeb 2017
First PostedMar 2017
Primary CompletionAug 2017
TodayJul 2026
First PostedMar 27, 2017
Enrollment StartFeb 28, 2017
Primary CompletionAug 3, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.3 years ago
Interventions
IW-1973drug
Oral Tablet
Placebodrug
Oral Tablet